Solution prescribed for UC

It is indicated for both the induction of clinical and endoscopic remission in active mild to moderate UC patients and the maintenance of remission. Mezavant XL utilises novel multi matrix system (MMX) prolonged release technology and offers the highest 5-ASA dose per tablet in the 5-ASA class.

According to SHIRE, Mezavant XL is the only licensed once daily tablet in the UK and offers the lowest pill burden of any 5-ASA (2 tablets once a day for maintenance of remission, 2-4 tablets once a day for induction of remission).